Streetbeat News

Stock Prices

PTC

PTC (NASDAQ:PTC) has delivered an average annual return of 15.2% over the past 5 years, outperforming the market by 2.57% annually. With a current market cap of $21.37 billion, a $1000 investment in PTC 5 years ago would now be worth $2,047.88.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 4:00 pm

MSFT

The article provides an in-depth comparison of Microsoft (NASDAQ:MSFT) against its peers in the Software industry, focusing on key financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Microsoft shows favorable growth potential with a lower P/E ratio than the industry average, potential undervaluation based on its P/B ratio, but a higher P/S ratio suggesting possible overvaluation. Its ROE is below the industry average, but it has significantly higher EBITDA and gross profit, indicating strong profitability and cash flow generation. Microsoft's revenue growth also outperforms the industry average.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 4:00 pm

PANL

Pangaea Logistics Solutions' stock trades lower following a downgrade from Buy to Neutral by Alliance Global Partners.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 3:59 pm

VRTX

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is set to release its Q4 earnings on Feb. 5, 2024, with analysts predicting an EPS of $4.10, up from $3.76 year-over-year, and revenue of $2.51 billion, up from $2.3 billion. The company recently announced positive results from its Phase 3 trials for VX-548. Shares fell 2.1% to $424.68 recently. Analysts from JP Morgan, Truist Securities, Canaccord Genuity, RBC Capital, and HC Wainwright & Co. have updated their ratings and price targets for VRTX.

Portfolio Pulse from Avi Kapoor

February 05, 2024 | 3:59 pm

NSSC

NAPCO Security Technologies' shares surged following the announcement of impressive Q2 financial results and a hike in its quarterly dividend. The company's performance exceeded market expectations, signaling strong operational efficiency and financial health.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 3:53 pm

JKS

JinkoSolar's stock price is trading lower following a downgrade by HSBC from Buy to Hold, along with a new price target of $30.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 3:52 pm

ADVM

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares surged after announcing a $127.5 million private placement at a premium, selling approximately 106.25 million shares at $1.20 each. The proceeds are expected to fund operations into late 2025. Additionally, Adverum will host a webcast on Feb. 8 to discuss preliminary data from its LUNA Phase 2 study. The stock's trading volume significantly increased following the announcement.

Portfolio Pulse from Erica Kollmann

February 05, 2024 | 3:50 pm

PTON

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Peloton Interactive (PTON) and reduced the price target from $6.5 to $5.75.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 3:49 pm

GFS

GlobalFoundries shares are trading lower following a downgrade by JP Morgan from Overweight to Neutral.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 3:49 pm

ELAN

MRK

Merck & Co Inc's division, Merck Animal Health, is set to acquire Elanco Animal Health Incorporated's aqua business for $1.3 billion in cash. This acquisition includes a portfolio of aquatic species products, two manufacturing facilities in Canada and Vietnam, and a research facility in Chile, aiming for completion by mid-2024. Elanco plans to use the proceeds to reduce its Term Loan B debt, expecting a net debt to adjusted EBITDA in the high-3x to low-4x range by end of 2025. ELAN shares rose 6.28% to $15.65.

Portfolio Pulse from Vandana Singh

February 05, 2024 | 3:49 pm